nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiodarone—CYP2A6—Prednisolone—multiple sclerosis	0.0627	0.105	CbGbCtD
Amiodarone—CYP2D6—Fingolimod—multiple sclerosis	0.0477	0.0802	CbGbCtD
Amiodarone—CYP2A6—Dexamethasone—multiple sclerosis	0.0369	0.0622	CbGbCtD
Amiodarone—ABCB1—Methylprednisolone—multiple sclerosis	0.0326	0.0548	CbGbCtD
Amiodarone—CYP1A1—Dexamethasone—multiple sclerosis	0.0316	0.0531	CbGbCtD
Amiodarone—CYP3A4—Fingolimod—multiple sclerosis	0.0303	0.051	CbGbCtD
Amiodarone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0253	0.0425	CbGbCtD
Amiodarone—CYP3A7—Dexamethasone—multiple sclerosis	0.0253	0.0425	CbGbCtD
Amiodarone—CYP2C19—Prednisone—multiple sclerosis	0.0245	0.0412	CbGbCtD
Amiodarone—ABCB1—Mitoxantrone—multiple sclerosis	0.0238	0.04	CbGbCtD
Amiodarone—ABCB1—Betamethasone—multiple sclerosis	0.0212	0.0357	CbGbCtD
Amiodarone—ABCB1—Prednisolone—multiple sclerosis	0.0209	0.0352	CbGbCtD
Amiodarone—ABCB1—Prednisone—multiple sclerosis	0.0197	0.0332	CbGbCtD
Amiodarone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0195	0.0329	CbGbCtD
Amiodarone—CYP3A5—Dexamethasone—multiple sclerosis	0.0189	0.0319	CbGbCtD
Amiodarone—CYP2C8—Dexamethasone—multiple sclerosis	0.0182	0.0306	CbGbCtD
Amiodarone—CYP2C19—Dexamethasone—multiple sclerosis	0.0153	0.0257	CbGbCtD
Amiodarone—CYP3A4—Triamcinolone—multiple sclerosis	0.0148	0.0249	CbGbCtD
Amiodarone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0142	0.024	CbGbCtD
Amiodarone—CYP2C9—Dexamethasone—multiple sclerosis	0.0127	0.0214	CbGbCtD
Amiodarone—CYP3A4—Betamethasone—multiple sclerosis	0.0127	0.0214	CbGbCtD
Amiodarone—CYP3A4—Prednisolone—multiple sclerosis	0.0125	0.0211	CbGbCtD
Amiodarone—ABCB1—Dexamethasone—multiple sclerosis	0.0123	0.0207	CbGbCtD
Amiodarone—CYP3A4—Prednisone—multiple sclerosis	0.0118	0.0199	CbGbCtD
Amiodarone—CYP2D6—Dexamethasone—multiple sclerosis	0.0116	0.0195	CbGbCtD
Amiodarone—ABCB1—Methotrexate—multiple sclerosis	0.00991	0.0167	CbGbCtD
Amiodarone—CYP3A4—Dexamethasone—multiple sclerosis	0.00739	0.0124	CbGbCtD
Amiodarone—Oxybuprocaine—BCHE—multiple sclerosis	0.00198	0.454	CrCbGaD
Amiodarone—Cinchocaine—BCHE—multiple sclerosis	0.00175	0.403	CrCbGaD
Amiodarone—EBP—Azacitidine—Cladribine—multiple sclerosis	0.00168	1	CbGdCrCtD
Amiodarone—THRB—brainstem—multiple sclerosis	0.00166	0.0591	CbGeAlD
Amiodarone—THRA—brainstem—multiple sclerosis	0.00166	0.0591	CbGeAlD
Amiodarone—CACNA2D2—midbrain—multiple sclerosis	0.00105	0.0373	CbGeAlD
Amiodarone—THRA—spinal cord—multiple sclerosis	0.00103	0.0368	CbGeAlD
Amiodarone—CACNA2D2—spinal cord—multiple sclerosis	0.00102	0.0364	CbGeAlD
Amiodarone—THRB—nervous system—multiple sclerosis	0.000872	0.031	CbGeAlD
Amiodarone—THRA—nervous system—multiple sclerosis	0.000872	0.031	CbGeAlD
Amiodarone—CACNA2D2—nervous system—multiple sclerosis	0.000863	0.0307	CbGeAlD
Amiodarone—THRB—central nervous system—multiple sclerosis	0.000839	0.0298	CbGeAlD
Amiodarone—THRA—central nervous system—multiple sclerosis	0.000839	0.0298	CbGeAlD
Amiodarone—CACNA2D2—central nervous system—multiple sclerosis	0.000831	0.0295	CbGeAlD
Amiodarone—THRB—cerebellum—multiple sclerosis	0.000821	0.0292	CbGeAlD
Amiodarone—THRA—cerebellum—multiple sclerosis	0.000821	0.0292	CbGeAlD
Amiodarone—CACNA2D2—cerebellum—multiple sclerosis	0.000812	0.0289	CbGeAlD
Amiodarone—CACNA1H—nervous system—multiple sclerosis	0.0007	0.0249	CbGeAlD
Amiodarone—THRB—brain—multiple sclerosis	0.000666	0.0237	CbGeAlD
Amiodarone—THRA—brain—multiple sclerosis	0.000666	0.0237	CbGeAlD
Amiodarone—CACNA2D2—brain—multiple sclerosis	0.000659	0.0234	CbGeAlD
Amiodarone—CACNA1H—cerebellum—multiple sclerosis	0.000658	0.0234	CbGeAlD
Amiodarone—Dronedarone—ALB—multiple sclerosis	0.000622	0.143	CrCbGaD
Amiodarone—CACNA1H—brain—multiple sclerosis	0.000535	0.019	CbGeAlD
Amiodarone—SIGMAR1—medulla oblongata—multiple sclerosis	0.000531	0.0189	CbGeAlD
Amiodarone—CYP2A6—cerebellum—multiple sclerosis	0.000487	0.0173	CbGeAlD
Amiodarone—SIGMAR1—midbrain—multiple sclerosis	0.000486	0.0173	CbGeAlD
Amiodarone—SIGMAR1—spinal cord—multiple sclerosis	0.000474	0.0168	CbGeAlD
Amiodarone—KCNH2—medulla oblongata—multiple sclerosis	0.000423	0.015	CbGeAlD
Amiodarone—ADRB1—nervous system—multiple sclerosis	0.000416	0.0148	CbGeAlD
Amiodarone—ADRB1—central nervous system—multiple sclerosis	0.000401	0.0142	CbGeAlD
Amiodarone—CYP2A6—brain—multiple sclerosis	0.000396	0.0141	CbGeAlD
Amiodarone—KCNH2—midbrain—multiple sclerosis	0.000386	0.0137	CbGeAlD
Amiodarone—KCNH2—spinal cord—multiple sclerosis	0.000377	0.0134	CbGeAlD
Amiodarone—SIGMAR1—cerebellum—multiple sclerosis	0.000376	0.0133	CbGeAlD
Amiodarone—CYP2D6—brainstem—multiple sclerosis	0.00037	0.0131	CbGeAlD
Amiodarone—ADRB1—brain—multiple sclerosis	0.000318	0.0113	CbGeAlD
Amiodarone—KCNH2—nervous system—multiple sclerosis	0.000318	0.0113	CbGeAlD
Amiodarone—KCNH2—central nervous system—multiple sclerosis	0.000306	0.0109	CbGeAlD
Amiodarone—SIGMAR1—brain—multiple sclerosis	0.000305	0.0108	CbGeAlD
Amiodarone—KCNH2—cerebellum—multiple sclerosis	0.000299	0.0106	CbGeAlD
Amiodarone—CYP1A1—nervous system—multiple sclerosis	0.000268	0.00953	CbGeAlD
Amiodarone—CYP1A1—central nervous system—multiple sclerosis	0.000258	0.00918	CbGeAlD
Amiodarone—ABCB1—retina—multiple sclerosis	0.000257	0.00912	CbGeAlD
Amiodarone—KCNH2—brain—multiple sclerosis	0.000243	0.00863	CbGeAlD
Amiodarone—CYP2C8—brain—multiple sclerosis	0.000222	0.0079	CbGeAlD
Amiodarone—CYP1A1—brain—multiple sclerosis	0.000205	0.00729	CbGeAlD
Amiodarone—CYP3A4—nervous system—multiple sclerosis	0.000197	0.007	CbGeAlD
Amiodarone—CYP2D6—nervous system—multiple sclerosis	0.000194	0.00688	CbGeAlD
Amiodarone—CYP3A4—central nervous system—multiple sclerosis	0.00019	0.00674	CbGeAlD
Amiodarone—CYP2D6—central nervous system—multiple sclerosis	0.000187	0.00663	CbGeAlD
Amiodarone—ABCB1—medulla oblongata—multiple sclerosis	0.000185	0.00659	CbGeAlD
Amiodarone—Shock—Prednisolone—multiple sclerosis	0.000184	0.000684	CcSEcCtD
Amiodarone—Erectile dysfunction—Methotrexate—multiple sclerosis	0.000184	0.000684	CcSEcCtD
Amiodarone—Cough—Triamcinolone—multiple sclerosis	0.000184	0.000684	CcSEcCtD
Amiodarone—Tachycardia—Prednisolone—multiple sclerosis	0.000183	0.000679	CcSEcCtD
Amiodarone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000182	0.000678	CcSEcCtD
Amiodarone—CYP2D6—cerebellum—multiple sclerosis	0.000182	0.00648	CbGeAlD
Amiodarone—Urticaria—Mitoxantrone—multiple sclerosis	0.000181	0.000673	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000181	0.000672	CcSEcCtD
Amiodarone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00018	0.00067	CcSEcCtD
Amiodarone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.00018	0.00067	CcSEcCtD
Amiodarone—Vomiting—Azathioprine—multiple sclerosis	0.000179	0.000667	CcSEcCtD
Amiodarone—Pneumonia—Methotrexate—multiple sclerosis	0.000179	0.000666	CcSEcCtD
Amiodarone—Anxiety—Methylprednisolone—multiple sclerosis	0.000178	0.000663	CcSEcCtD
Amiodarone—Rash—Azathioprine—multiple sclerosis	0.000178	0.000661	CcSEcCtD
Amiodarone—Dermatitis—Azathioprine—multiple sclerosis	0.000178	0.000661	CcSEcCtD
Amiodarone—Flushing—Prednisone—multiple sclerosis	0.000178	0.00066	CcSEcCtD
Amiodarone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000177	0.00066	CcSEcCtD
Amiodarone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000177	0.00066	CcSEcCtD
Amiodarone—Discomfort—Triamcinolone—multiple sclerosis	0.000177	0.000659	CcSEcCtD
Amiodarone—Discomfort—Methylprednisolone—multiple sclerosis	0.000177	0.000658	CcSEcCtD
Amiodarone—Headache—Azathioprine—multiple sclerosis	0.000177	0.000657	CcSEcCtD
Amiodarone—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000177	0.000657	CcSEcCtD
Amiodarone—Dry mouth—Triamcinolone—multiple sclerosis	0.000176	0.000652	CcSEcCtD
Amiodarone—Renal failure—Methotrexate—multiple sclerosis	0.000175	0.000651	CcSEcCtD
Amiodarone—Angioedema—Betamethasone—multiple sclerosis	0.000175	0.00065	CcSEcCtD
Amiodarone—Angioedema—Dexamethasone—multiple sclerosis	0.000175	0.00065	CcSEcCtD
Amiodarone—Confusional state—Methylprednisolone—multiple sclerosis	0.000173	0.000643	CcSEcCtD
Amiodarone—Malaise—Dexamethasone—multiple sclerosis	0.000173	0.000641	CcSEcCtD
Amiodarone—Malaise—Betamethasone—multiple sclerosis	0.000173	0.000641	CcSEcCtD
Amiodarone—Oedema—Triamcinolone—multiple sclerosis	0.000172	0.00064	CcSEcCtD
Amiodarone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000172	0.00064	CcSEcCtD
Amiodarone—Vertigo—Dexamethasone—multiple sclerosis	0.000172	0.000639	CcSEcCtD
Amiodarone—Vertigo—Betamethasone—multiple sclerosis	0.000172	0.000639	CcSEcCtD
Amiodarone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000172	0.000638	CcSEcCtD
Amiodarone—Arrhythmia—Prednisone—multiple sclerosis	0.000171	0.000635	CcSEcCtD
Amiodarone—Infection—Triamcinolone—multiple sclerosis	0.000171	0.000635	CcSEcCtD
Amiodarone—Sweating—Methotrexate—multiple sclerosis	0.000171	0.000635	CcSEcCtD
Amiodarone—Infection—Methylprednisolone—multiple sclerosis	0.000171	0.000634	CcSEcCtD
Amiodarone—ABCB1—midbrain—multiple sclerosis	0.00017	0.00602	CbGeAlD
Amiodarone—Shock—Triamcinolone—multiple sclerosis	0.000169	0.000629	CcSEcCtD
Amiodarone—Insomnia—Prednisolone—multiple sclerosis	0.000169	0.000629	CcSEcCtD
Amiodarone—Alopecia—Prednisone—multiple sclerosis	0.000169	0.000629	CcSEcCtD
Amiodarone—Shock—Methylprednisolone—multiple sclerosis	0.000169	0.000628	CcSEcCtD
Amiodarone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000168	0.000625	CcSEcCtD
Amiodarone—Paraesthesia—Prednisolone—multiple sclerosis	0.000168	0.000624	CcSEcCtD
Amiodarone—Tachycardia—Triamcinolone—multiple sclerosis	0.000168	0.000624	CcSEcCtD
Amiodarone—Nausea—Azathioprine—multiple sclerosis	0.000168	0.000623	CcSEcCtD
Amiodarone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000168	0.000623	CcSEcCtD
Amiodarone—Skin disorder—Methylprednisolone—multiple sclerosis	0.000167	0.00062	CcSEcCtD
Amiodarone—Erythema—Prednisone—multiple sclerosis	0.000167	0.000619	CcSEcCtD
Amiodarone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000166	0.000618	CcSEcCtD
Amiodarone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000166	0.000618	CcSEcCtD
Amiodarone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000166	0.000617	CcSEcCtD
Amiodarone—ABCB1—spinal cord—multiple sclerosis	0.000165	0.00588	CbGeAlD
Amiodarone—Asthenia—Mitoxantrone—multiple sclerosis	0.000164	0.000608	CcSEcCtD
Amiodarone—Anxiety—Dexamethasone—multiple sclerosis	0.000162	0.000603	CcSEcCtD
Amiodarone—Anxiety—Betamethasone—multiple sclerosis	0.000162	0.000603	CcSEcCtD
Amiodarone—Discomfort—Betamethasone—multiple sclerosis	0.000161	0.000598	CcSEcCtD
Amiodarone—Discomfort—Dexamethasone—multiple sclerosis	0.000161	0.000598	CcSEcCtD
Amiodarone—Hypotension—Methylprednisolone—multiple sclerosis	0.00016	0.000596	CcSEcCtD
Amiodarone—Pain—Prednisolone—multiple sclerosis	0.00016	0.000595	CcSEcCtD
Amiodarone—Hepatitis—Methotrexate—multiple sclerosis	0.00016	0.000594	CcSEcCtD
Amiodarone—Vision blurred—Prednisone—multiple sclerosis	0.000157	0.000584	CcSEcCtD
Amiodarone—Oedema—Betamethasone—multiple sclerosis	0.000156	0.00058	CcSEcCtD
Amiodarone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000156	0.00058	CcSEcCtD
Amiodarone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000156	0.00058	CcSEcCtD
Amiodarone—Oedema—Dexamethasone—multiple sclerosis	0.000156	0.00058	CcSEcCtD
Amiodarone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000156	0.00058	CcSEcCtD
Amiodarone—Insomnia—Triamcinolone—multiple sclerosis	0.000156	0.000578	CcSEcCtD
Amiodarone—Insomnia—Methylprednisolone—multiple sclerosis	0.000155	0.000577	CcSEcCtD
Amiodarone—Infection—Betamethasone—multiple sclerosis	0.000155	0.000577	CcSEcCtD
Amiodarone—Infection—Dexamethasone—multiple sclerosis	0.000155	0.000577	CcSEcCtD
Amiodarone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000155	0.000575	CcSEcCtD
Amiodarone—Paraesthesia—Triamcinolone—multiple sclerosis	0.000155	0.000574	CcSEcCtD
Amiodarone—Feeling abnormal—Prednisolone—multiple sclerosis	0.000154	0.000573	CcSEcCtD
Amiodarone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000154	0.000573	CcSEcCtD
Amiodarone—Visual impairment—Methotrexate—multiple sclerosis	0.000154	0.000573	CcSEcCtD
Amiodarone—Shock—Dexamethasone—multiple sclerosis	0.000154	0.000571	CcSEcCtD
Amiodarone—Shock—Betamethasone—multiple sclerosis	0.000154	0.000571	CcSEcCtD
Amiodarone—Dyspnoea—Triamcinolone—multiple sclerosis	0.000153	0.00057	CcSEcCtD
Amiodarone—Agitation—Prednisone—multiple sclerosis	0.000153	0.000569	CcSEcCtD
Amiodarone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000153	0.000568	CcSEcCtD
Amiodarone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000153	0.000568	CcSEcCtD
Amiodarone—Tachycardia—Betamethasone—multiple sclerosis	0.000152	0.000566	CcSEcCtD
Amiodarone—Tachycardia—Dexamethasone—multiple sclerosis	0.000152	0.000566	CcSEcCtD
Amiodarone—Angioedema—Prednisone—multiple sclerosis	0.000152	0.000566	CcSEcCtD
Amiodarone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000151	0.000563	CcSEcCtD
Amiodarone—Erythema multiforme—Methotrexate—multiple sclerosis	0.000151	0.000562	CcSEcCtD
Amiodarone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000151	0.000562	CcSEcCtD
Amiodarone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000151	0.000561	CcSEcCtD
Amiodarone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000151	0.000561	CcSEcCtD
Amiodarone—Malaise—Prednisone—multiple sclerosis	0.00015	0.000558	CcSEcCtD
Amiodarone—Vertigo—Prednisone—multiple sclerosis	0.00015	0.000556	CcSEcCtD
Amiodarone—Tinnitus—Methotrexate—multiple sclerosis	0.000149	0.000554	CcSEcCtD
Amiodarone—Anorexia—Dexamethasone—multiple sclerosis	0.000149	0.000553	CcSEcCtD
Amiodarone—Anorexia—Betamethasone—multiple sclerosis	0.000149	0.000553	CcSEcCtD
Amiodarone—Urticaria—Prednisolone—multiple sclerosis	0.000149	0.000552	CcSEcCtD
Amiodarone—Fatigue—Triamcinolone—multiple sclerosis	0.000148	0.000551	CcSEcCtD
Amiodarone—CYP2D6—brain—multiple sclerosis	0.000148	0.00526	CbGeAlD
Amiodarone—Fatigue—Methylprednisolone—multiple sclerosis	0.000148	0.00055	CcSEcCtD
Amiodarone—Pain—Triamcinolone—multiple sclerosis	0.000147	0.000547	CcSEcCtD
Amiodarone—Hypotension—Betamethasone—multiple sclerosis	0.000146	0.000542	CcSEcCtD
Amiodarone—Hypotension—Dexamethasone—multiple sclerosis	0.000146	0.000542	CcSEcCtD
Amiodarone—Vomiting—Mitoxantrone—multiple sclerosis	0.000145	0.000539	CcSEcCtD
Amiodarone—Rash—Mitoxantrone—multiple sclerosis	0.000144	0.000534	CcSEcCtD
Amiodarone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000144	0.000534	CcSEcCtD
Amiodarone—Headache—Mitoxantrone—multiple sclerosis	0.000143	0.000531	CcSEcCtD
Amiodarone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000142	0.000527	CcSEcCtD
Amiodarone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000141	0.000526	CcSEcCtD
Amiodarone—Anxiety—Prednisone—multiple sclerosis	0.000141	0.000525	CcSEcCtD
Amiodarone—Alopecia—Methotrexate—multiple sclerosis	0.000141	0.000525	CcSEcCtD
Amiodarone—Insomnia—Dexamethasone—multiple sclerosis	0.000141	0.000525	CcSEcCtD
Amiodarone—Insomnia—Betamethasone—multiple sclerosis	0.000141	0.000525	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.00014	0.000522	CcSEcCtD
Amiodarone—Paraesthesia—Betamethasone—multiple sclerosis	0.00014	0.000521	CcSEcCtD
Amiodarone—Paraesthesia—Dexamethasone—multiple sclerosis	0.00014	0.000521	CcSEcCtD
Amiodarone—Discomfort—Prednisone—multiple sclerosis	0.00014	0.000521	CcSEcCtD
Amiodarone—ABCB1—nervous system—multiple sclerosis	0.000139	0.00495	CbGeAlD
Amiodarone—Erythema—Methotrexate—multiple sclerosis	0.000139	0.000518	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000138	0.000512	CcSEcCtD
Amiodarone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000137	0.000511	CcSEcCtD
Amiodarone—Dyspepsia—Betamethasone—multiple sclerosis	0.000137	0.000511	CcSEcCtD
Amiodarone—Urticaria—Triamcinolone—multiple sclerosis	0.000137	0.000508	CcSEcCtD
Amiodarone—Urticaria—Methylprednisolone—multiple sclerosis	0.000136	0.000507	CcSEcCtD
Amiodarone—Dysgeusia—Methotrexate—multiple sclerosis	0.000136	0.000507	CcSEcCtD
Amiodarone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000136	0.000506	CcSEcCtD
Amiodarone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000136	0.000505	CcSEcCtD
Amiodarone—Oedema—Prednisone—multiple sclerosis	0.000136	0.000505	CcSEcCtD
Amiodarone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000136	0.000504	CcSEcCtD
Amiodarone—Decreased appetite—Dexamethasone—multiple sclerosis	0.000136	0.000504	CcSEcCtD
Amiodarone—Decreased appetite—Betamethasone—multiple sclerosis	0.000136	0.000504	CcSEcCtD
Amiodarone—Nausea—Mitoxantrone—multiple sclerosis	0.000135	0.000504	CcSEcCtD
Amiodarone—Infection—Prednisone—multiple sclerosis	0.000135	0.000502	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000135	0.000501	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000135	0.000501	CcSEcCtD
Amiodarone—Back pain—Methotrexate—multiple sclerosis	0.000135	0.000501	CcSEcCtD
Amiodarone—Fatigue—Betamethasone—multiple sclerosis	0.000135	0.0005	CcSEcCtD
Amiodarone—Fatigue—Dexamethasone—multiple sclerosis	0.000135	0.0005	CcSEcCtD
Amiodarone—ABCB1—central nervous system—multiple sclerosis	0.000134	0.00477	CbGeAlD
Amiodarone—Shock—Prednisone—multiple sclerosis	0.000134	0.000497	CcSEcCtD
Amiodarone—Pain—Dexamethasone—multiple sclerosis	0.000134	0.000496	CcSEcCtD
Amiodarone—Pain—Betamethasone—multiple sclerosis	0.000134	0.000496	CcSEcCtD
Amiodarone—Tachycardia—Prednisone—multiple sclerosis	0.000133	0.000493	CcSEcCtD
Amiodarone—Skin disorder—Prednisone—multiple sclerosis	0.000132	0.000491	CcSEcCtD
Amiodarone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000131	0.000489	CcSEcCtD
Amiodarone—Vision blurred—Methotrexate—multiple sclerosis	0.000131	0.000488	CcSEcCtD
Amiodarone—ABCB1—cerebellum—multiple sclerosis	0.000131	0.00466	CbGeAlD
Amiodarone—Anorexia—Prednisone—multiple sclerosis	0.00013	0.000482	CcSEcCtD
Amiodarone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000129	0.00048	CcSEcCtD
Amiodarone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000129	0.000478	CcSEcCtD
Amiodarone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000129	0.000478	CcSEcCtD
Amiodarone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000128	0.000475	CcSEcCtD
Amiodarone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000128	0.000475	CcSEcCtD
Amiodarone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000127	0.000471	CcSEcCtD
Amiodarone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000126	0.00047	CcSEcCtD
Amiodarone—Malaise—Methotrexate—multiple sclerosis	0.000126	0.000467	CcSEcCtD
Amiodarone—Vertigo—Methotrexate—multiple sclerosis	0.000125	0.000465	CcSEcCtD
Amiodarone—Urticaria—Betamethasone—multiple sclerosis	0.000124	0.000461	CcSEcCtD
Amiodarone—Urticaria—Dexamethasone—multiple sclerosis	0.000124	0.000461	CcSEcCtD
Amiodarone—Dizziness—Prednisolone—multiple sclerosis	0.000124	0.00046	CcSEcCtD
Amiodarone—Asthenia—Triamcinolone—multiple sclerosis	0.000123	0.000459	CcSEcCtD
Amiodarone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000123	0.000459	CcSEcCtD
Amiodarone—Body temperature increased—Betamethasone—multiple sclerosis	0.000123	0.000459	CcSEcCtD
Amiodarone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000123	0.000459	CcSEcCtD
Amiodarone—Abdominal pain—Betamethasone—multiple sclerosis	0.000123	0.000459	CcSEcCtD
Amiodarone—Asthenia—Methylprednisolone—multiple sclerosis	0.000123	0.000458	CcSEcCtD
Amiodarone—Insomnia—Prednisone—multiple sclerosis	0.000123	0.000457	CcSEcCtD
Amiodarone—Paraesthesia—Prednisone—multiple sclerosis	0.000122	0.000454	CcSEcCtD
Amiodarone—Pruritus—Triamcinolone—multiple sclerosis	0.000122	0.000452	CcSEcCtD
Amiodarone—Cough—Methotrexate—multiple sclerosis	0.000121	0.000452	CcSEcCtD
Amiodarone—Pruritus—Methylprednisolone—multiple sclerosis	0.000121	0.000451	CcSEcCtD
Amiodarone—Dyspepsia—Prednisone—multiple sclerosis	0.00012	0.000445	CcSEcCtD
Amiodarone—Decreased appetite—Prednisone—multiple sclerosis	0.000118	0.000439	CcSEcCtD
Amiodarone—Rash—Prednisolone—multiple sclerosis	0.000118	0.000439	CcSEcCtD
Amiodarone—Dermatitis—Prednisolone—multiple sclerosis	0.000118	0.000438	CcSEcCtD
Amiodarone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000117	0.000437	CcSEcCtD
Amiodarone—Fatigue—Prednisone—multiple sclerosis	0.000117	0.000436	CcSEcCtD
Amiodarone—Headache—Prednisolone—multiple sclerosis	0.000117	0.000436	CcSEcCtD
Amiodarone—Discomfort—Methotrexate—multiple sclerosis	0.000117	0.000435	CcSEcCtD
Amiodarone—Constipation—Prednisone—multiple sclerosis	0.000116	0.000432	CcSEcCtD
Amiodarone—Confusional state—Methotrexate—multiple sclerosis	0.000115	0.000426	CcSEcCtD
Amiodarone—Dizziness—Triamcinolone—multiple sclerosis	0.000114	0.000423	CcSEcCtD
Amiodarone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000114	0.000422	CcSEcCtD
Amiodarone—Dizziness—Methylprednisolone—multiple sclerosis	0.000114	0.000422	CcSEcCtD
Amiodarone—Infection—Methotrexate—multiple sclerosis	0.000113	0.00042	CcSEcCtD
Amiodarone—Feeling abnormal—Prednisone—multiple sclerosis	0.000112	0.000416	CcSEcCtD
Amiodarone—Asthenia—Betamethasone—multiple sclerosis	0.000112	0.000416	CcSEcCtD
Amiodarone—Asthenia—Dexamethasone—multiple sclerosis	0.000112	0.000416	CcSEcCtD
Amiodarone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000111	0.000414	CcSEcCtD
Amiodarone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000111	0.000413	CcSEcCtD
Amiodarone—Nausea—Prednisolone—multiple sclerosis	0.000111	0.000413	CcSEcCtD
Amiodarone—Pruritus—Dexamethasone—multiple sclerosis	0.00011	0.000411	CcSEcCtD
Amiodarone—Pruritus—Betamethasone—multiple sclerosis	0.00011	0.000411	CcSEcCtD
Amiodarone—Skin disorder—Methotrexate—multiple sclerosis	0.00011	0.00041	CcSEcCtD
Amiodarone—Hyperhidrosis—Methotrexate—multiple sclerosis	0.00011	0.000408	CcSEcCtD
Amiodarone—Vomiting—Triamcinolone—multiple sclerosis	0.000109	0.000407	CcSEcCtD
Amiodarone—Vomiting—Methylprednisolone—multiple sclerosis	0.000109	0.000406	CcSEcCtD
Amiodarone—Rash—Triamcinolone—multiple sclerosis	0.000108	0.000403	CcSEcCtD
Amiodarone—Dermatitis—Triamcinolone—multiple sclerosis	0.000108	0.000403	CcSEcCtD
Amiodarone—Anorexia—Methotrexate—multiple sclerosis	0.000108	0.000403	CcSEcCtD
Amiodarone—Rash—Methylprednisolone—multiple sclerosis	0.000108	0.000402	CcSEcCtD
Amiodarone—Dermatitis—Methylprednisolone—multiple sclerosis	0.000108	0.000402	CcSEcCtD
Amiodarone—Urticaria—Prednisone—multiple sclerosis	0.000108	0.000401	CcSEcCtD
Amiodarone—Headache—Triamcinolone—multiple sclerosis	0.000108	0.000401	CcSEcCtD
Amiodarone—Headache—Methylprednisolone—multiple sclerosis	0.000108	0.0004	CcSEcCtD
Amiodarone—Abdominal pain—Prednisone—multiple sclerosis	0.000107	0.0004	CcSEcCtD
Amiodarone—Body temperature increased—Prednisone—multiple sclerosis	0.000107	0.0004	CcSEcCtD
Amiodarone—Diarrhoea—Dexamethasone—multiple sclerosis	0.000107	0.000397	CcSEcCtD
Amiodarone—Diarrhoea—Betamethasone—multiple sclerosis	0.000107	0.000397	CcSEcCtD
Amiodarone—ABCB1—brain—multiple sclerosis	0.000107	0.00379	CbGeAlD
Amiodarone—Hypotension—Methotrexate—multiple sclerosis	0.000106	0.000395	CcSEcCtD
Amiodarone—Dizziness—Betamethasone—multiple sclerosis	0.000103	0.000384	CcSEcCtD
Amiodarone—Dizziness—Dexamethasone—multiple sclerosis	0.000103	0.000384	CcSEcCtD
Amiodarone—Insomnia—Methotrexate—multiple sclerosis	0.000103	0.000382	CcSEcCtD
Amiodarone—Nausea—Triamcinolone—multiple sclerosis	0.000102	0.00038	CcSEcCtD
Amiodarone—Paraesthesia—Methotrexate—multiple sclerosis	0.000102	0.000379	CcSEcCtD
Amiodarone—Nausea—Methylprednisolone—multiple sclerosis	0.000102	0.000379	CcSEcCtD
Amiodarone—Dyspnoea—Methotrexate—multiple sclerosis	0.000101	0.000377	CcSEcCtD
Amiodarone—Hypersensitivity—Prednisone—multiple sclerosis	0.0001	0.000372	CcSEcCtD
Amiodarone—Dyspepsia—Methotrexate—multiple sclerosis	0.0001	0.000372	CcSEcCtD
Amiodarone—Vomiting—Betamethasone—multiple sclerosis	9.93e-05	0.000369	CcSEcCtD
Amiodarone—Vomiting—Dexamethasone—multiple sclerosis	9.93e-05	0.000369	CcSEcCtD
Amiodarone—Decreased appetite—Methotrexate—multiple sclerosis	9.88e-05	0.000367	CcSEcCtD
Amiodarone—Rash—Betamethasone—multiple sclerosis	9.84e-05	0.000366	CcSEcCtD
Amiodarone—Rash—Dexamethasone—multiple sclerosis	9.84e-05	0.000366	CcSEcCtD
Amiodarone—Dermatitis—Dexamethasone—multiple sclerosis	9.84e-05	0.000366	CcSEcCtD
Amiodarone—Dermatitis—Betamethasone—multiple sclerosis	9.84e-05	0.000366	CcSEcCtD
Amiodarone—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.81e-05	0.000365	CcSEcCtD
Amiodarone—Fatigue—Methotrexate—multiple sclerosis	9.8e-05	0.000364	CcSEcCtD
Amiodarone—Headache—Dexamethasone—multiple sclerosis	9.78e-05	0.000364	CcSEcCtD
Amiodarone—Headache—Betamethasone—multiple sclerosis	9.78e-05	0.000364	CcSEcCtD
Amiodarone—Asthenia—Prednisone—multiple sclerosis	9.76e-05	0.000363	CcSEcCtD
Amiodarone—Pain—Methotrexate—multiple sclerosis	9.72e-05	0.000361	CcSEcCtD
Amiodarone—Pruritus—Prednisone—multiple sclerosis	9.62e-05	0.000358	CcSEcCtD
Amiodarone—Feeling abnormal—Methotrexate—multiple sclerosis	9.36e-05	0.000348	CcSEcCtD
Amiodarone—Diarrhoea—Prednisone—multiple sclerosis	9.3e-05	0.000346	CcSEcCtD
Amiodarone—Gastrointestinal pain—Methotrexate—multiple sclerosis	9.29e-05	0.000345	CcSEcCtD
Amiodarone—Nausea—Dexamethasone—multiple sclerosis	9.27e-05	0.000345	CcSEcCtD
Amiodarone—Nausea—Betamethasone—multiple sclerosis	9.27e-05	0.000345	CcSEcCtD
Amiodarone—Urticaria—Methotrexate—multiple sclerosis	9.03e-05	0.000336	CcSEcCtD
Amiodarone—Dizziness—Prednisone—multiple sclerosis	8.99e-05	0.000334	CcSEcCtD
Amiodarone—Body temperature increased—Methotrexate—multiple sclerosis	8.98e-05	0.000334	CcSEcCtD
Amiodarone—Abdominal pain—Methotrexate—multiple sclerosis	8.98e-05	0.000334	CcSEcCtD
Amiodarone—Vomiting—Prednisone—multiple sclerosis	8.64e-05	0.000321	CcSEcCtD
Amiodarone—Rash—Prednisone—multiple sclerosis	8.57e-05	0.000319	CcSEcCtD
Amiodarone—Dermatitis—Prednisone—multiple sclerosis	8.57e-05	0.000318	CcSEcCtD
Amiodarone—Headache—Prednisone—multiple sclerosis	8.52e-05	0.000317	CcSEcCtD
Amiodarone—Hypersensitivity—Methotrexate—multiple sclerosis	8.37e-05	0.000311	CcSEcCtD
Amiodarone—Asthenia—Methotrexate—multiple sclerosis	8.15e-05	0.000303	CcSEcCtD
Amiodarone—Nausea—Prednisone—multiple sclerosis	8.08e-05	0.0003	CcSEcCtD
Amiodarone—Pruritus—Methotrexate—multiple sclerosis	8.04e-05	0.000299	CcSEcCtD
Amiodarone—Diarrhoea—Methotrexate—multiple sclerosis	7.77e-05	0.000289	CcSEcCtD
Amiodarone—Dizziness—Methotrexate—multiple sclerosis	7.51e-05	0.000279	CcSEcCtD
Amiodarone—Vomiting—Methotrexate—multiple sclerosis	7.22e-05	0.000269	CcSEcCtD
Amiodarone—Rash—Methotrexate—multiple sclerosis	7.16e-05	0.000266	CcSEcCtD
Amiodarone—Dermatitis—Methotrexate—multiple sclerosis	7.16e-05	0.000266	CcSEcCtD
Amiodarone—Headache—Methotrexate—multiple sclerosis	7.12e-05	0.000265	CcSEcCtD
Amiodarone—Nausea—Methotrexate—multiple sclerosis	6.75e-05	0.000251	CcSEcCtD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.98e-05	0.000583	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	5.96e-05	0.000582	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.95e-05	0.000581	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	5.94e-05	0.00058	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—MAPK1—multiple sclerosis	5.92e-05	0.000578	CbGpPWpGaD
Amiodarone—CYP2A6—Biological oxidations—POMC—multiple sclerosis	5.9e-05	0.000576	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CNR1—multiple sclerosis	5.84e-05	0.00057	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—RGS1—multiple sclerosis	5.81e-05	0.000567	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.6e-05	0.000547	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.6e-05	0.000547	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL13—multiple sclerosis	5.55e-05	0.000542	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CCR1—multiple sclerosis	5.55e-05	0.000542	CbGpPWpGaD
Amiodarone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	5.54e-05	0.000541	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—GPR65—multiple sclerosis	5.51e-05	0.000538	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	5.45e-05	0.000532	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	5.35e-05	0.000523	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—LINGO1—multiple sclerosis	5.33e-05	0.00052	CbGpPWpGaD
Amiodarone—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.28e-05	0.000515	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CXCL10—multiple sclerosis	5.26e-05	0.000513	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MMP9—multiple sclerosis	5.23e-05	0.00051	CbGpPWpGaD
Amiodarone—EBP—Metabolism—APOE—multiple sclerosis	5.15e-05	0.000503	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCR1—multiple sclerosis	5.04e-05	0.000492	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL13—multiple sclerosis	5.04e-05	0.000492	CbGpPWpGaD
Amiodarone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.03e-05	0.000491	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—SRM—multiple sclerosis	5.02e-05	0.00049	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	4.9e-05	0.000478	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	4.9e-05	0.000478	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.86e-05	0.000474	CbGpPWpGaD
Amiodarone—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.84e-05	0.000472	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.84e-05	0.000472	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	4.79e-05	0.000467	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.79e-05	0.000467	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.79e-05	0.000467	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—SRM—multiple sclerosis	4.75e-05	0.000463	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.66e-05	0.000454	CbGpPWpGaD
Amiodarone—CYP3A5—Biological oxidations—POMC—multiple sclerosis	4.65e-05	0.000454	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.65e-05	0.000454	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—STAT3—multiple sclerosis	4.65e-05	0.000454	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.64e-05	0.000453	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TAGAP—multiple sclerosis	4.62e-05	0.000451	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.55e-05	0.000445	CbGpPWpGaD
Amiodarone—CACNA1H—Axon guidance—IL6—multiple sclerosis	4.55e-05	0.000444	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CCL5—multiple sclerosis	4.53e-05	0.000442	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	4.49e-05	0.000438	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	4.49e-05	0.000438	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—GPC5—multiple sclerosis	4.48e-05	0.000437	CbGpPWpGaD
Amiodarone—EBP—Metabolism—POMC—multiple sclerosis	4.43e-05	0.000432	CbGpPWpGaD
Amiodarone—CYP1A1—Biological oxidations—POMC—multiple sclerosis	4.4e-05	0.000429	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—SRM—multiple sclerosis	4.35e-05	0.000425	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.34e-05	0.000423	CbGpPWpGaD
Amiodarone—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.34e-05	0.000423	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TGFB1—multiple sclerosis	4.31e-05	0.00042	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—MAPK1—multiple sclerosis	4.22e-05	0.000412	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.19e-05	0.000409	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—GPC5—multiple sclerosis	4.1e-05	0.000401	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.1e-05	0.0004	CbGpPWpGaD
Amiodarone—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.09e-05	0.0004	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CCR5—multiple sclerosis	4.08e-05	0.000398	CbGpPWpGaD
Amiodarone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.07e-05	0.000398	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—S1PR1—multiple sclerosis	4.04e-05	0.000394	CbGpPWpGaD
Amiodarone—EBP—Metabolism—ALB—multiple sclerosis	4.03e-05	0.000394	CbGpPWpGaD
Amiodarone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	4.03e-05	0.000394	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—TNF—multiple sclerosis	4.02e-05	0.000393	CbGpPWpGaD
Amiodarone—KCNH2—Neuronal System—MAPK1—multiple sclerosis	3.96e-05	0.000386	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GPC5—multiple sclerosis	3.93e-05	0.000383	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—SRM—multiple sclerosis	3.88e-05	0.000379	CbGpPWpGaD
Amiodarone—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.88e-05	0.000379	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—PTGER4—multiple sclerosis	3.81e-05	0.000372	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—SRM—multiple sclerosis	3.79e-05	0.00037	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.77e-05	0.000368	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—RRM1—multiple sclerosis	3.71e-05	0.000362	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCR3—multiple sclerosis	3.68e-05	0.000359	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.67e-05	0.000359	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—APOE—multiple sclerosis	3.67e-05	0.000358	CbGpPWpGaD
Amiodarone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.6e-05	0.000351	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL3—multiple sclerosis	3.59e-05	0.000351	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CCR2—multiple sclerosis	3.58e-05	0.000349	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—SRM—multiple sclerosis	3.57e-05	0.000349	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—SRM—multiple sclerosis	3.54e-05	0.000346	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	3.54e-05	0.000345	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	3.54e-05	0.000345	CbGpPWpGaD
Amiodarone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	3.52e-05	0.000344	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—PTGER4—multiple sclerosis	3.46e-05	0.000337	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—RGS1—multiple sclerosis	3.43e-05	0.000335	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.4e-05	0.000332	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP27B1—multiple sclerosis	3.34e-05	0.000326	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—CYP24A1—multiple sclerosis	3.34e-05	0.000326	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCR3—multiple sclerosis	3.34e-05	0.000326	CbGpPWpGaD
Amiodarone—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.31e-05	0.000323	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CNR1—multiple sclerosis	3.3e-05	0.000322	CbGpPWpGaD
Amiodarone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.28e-05	0.00032	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.27e-05	0.000319	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—GPR65—multiple sclerosis	3.26e-05	0.000318	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.25e-05	0.000317	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCR2—multiple sclerosis	3.25e-05	0.000317	CbGpPWpGaD
Amiodarone—CACNA1H—Developmental Biology—IL6—multiple sclerosis	3.25e-05	0.000317	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—GPC5—multiple sclerosis	3.24e-05	0.000316	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—POMC—multiple sclerosis	3.19e-05	0.000311	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—POMC—multiple sclerosis	3.15e-05	0.000308	CbGpPWpGaD
Amiodarone—ADRB1—GPCR ligand binding—CCL2—multiple sclerosis	3.12e-05	0.000304	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	3.07e-05	0.000299	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	3.07e-05	0.000299	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—GPC5—multiple sclerosis	3.06e-05	0.000298	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—SRM—multiple sclerosis	3.03e-05	0.000295	CbGpPWpGaD
Amiodarone—THRB—Gene Expression—MYC—multiple sclerosis	3.01e-05	0.000294	CbGpPWpGaD
Amiodarone—THRA—Gene Expression—MYC—multiple sclerosis	3.01e-05	0.000294	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CNR1—multiple sclerosis	3e-05	0.000293	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3e-05	0.000292	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL13—multiple sclerosis	2.98e-05	0.000291	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCR1—multiple sclerosis	2.98e-05	0.000291	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CXCL10—multiple sclerosis	2.97e-05	0.00029	CbGpPWpGaD
Amiodarone—CACNA2D2—Metabolism—ALB—multiple sclerosis	2.87e-05	0.000281	CbGpPWpGaD
Amiodarone—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.8e-05	0.000274	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—GPC5—multiple sclerosis	2.8e-05	0.000274	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.74e-05	0.000267	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.74e-05	0.000267	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CXCL10—multiple sclerosis	2.7e-05	0.000263	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—RRM1—multiple sclerosis	2.68e-05	0.000262	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.67e-05	0.000261	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.67e-05	0.000261	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.67e-05	0.000261	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CCL5—multiple sclerosis	2.56e-05	0.00025	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—RRM1—multiple sclerosis	2.53e-05	0.000247	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.52e-05	0.000246	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.52e-05	0.000246	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.5e-05	0.000244	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.49e-05	0.000244	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.49e-05	0.000244	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.44e-05	0.000238	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.44e-05	0.000238	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—SRM—multiple sclerosis	2.34e-05	0.000228	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—RRM1—multiple sclerosis	2.32e-05	0.000227	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL5—multiple sclerosis	2.32e-05	0.000227	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—CCR5—multiple sclerosis	2.3e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.3e-05	0.000225	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.28e-05	0.000223	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	2.27e-05	0.000222	CbGpPWpGaD
Amiodarone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.16e-05	0.000211	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.13e-05	0.000208	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.13e-05	0.000208	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.13e-05	0.000208	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	2.12e-05	0.000207	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	2.09e-05	0.000204	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.08e-05	0.000203	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.07e-05	0.000202	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	2.06e-05	0.000201	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	2.04e-05	0.000199	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—RRM1—multiple sclerosis	2.02e-05	0.000198	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—PGR—multiple sclerosis	2.01e-05	0.000196	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	1.97e-05	0.000193	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.97e-05	0.000192	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD28—multiple sclerosis	1.95e-05	0.000191	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.95e-05	0.000191	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.95e-05	0.00019	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	1.92e-05	0.000187	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.91e-05	0.000186	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.89e-05	0.000185	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.87e-05	0.000182	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.86e-05	0.000182	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.83e-05	0.000178	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.8e-05	0.000176	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	1.8e-05	0.000176	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	1.77e-05	0.000173	CbGpPWpGaD
Amiodarone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.74e-05	0.00017	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.69e-05	0.000165	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.65e-05	0.000161	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.65e-05	0.000161	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	1.64e-05	0.00016	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.62e-05	0.000158	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.61e-05	0.000157	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	1.6e-05	0.000156	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	1.59e-05	0.000156	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.55e-05	0.000151	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—BCHE—multiple sclerosis	1.54e-05	0.00015	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.54e-05	0.00015	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.5e-05	0.000147	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.47e-05	0.000143	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—BCHE—multiple sclerosis	1.46e-05	0.000142	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	1.45e-05	0.000142	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.41e-05	0.000138	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD86—multiple sclerosis	1.39e-05	0.000136	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.38e-05	0.000135	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	1.37e-05	0.000134	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.33e-05	0.00013	CbGpPWpGaD
Amiodarone—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	1.33e-05	0.00013	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—APOE—multiple sclerosis	1.28e-05	0.000125	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	1.27e-05	0.000124	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.26e-05	0.000123	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.26e-05	0.000123	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.25e-05	0.000122	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.25e-05	0.000122	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	1.24e-05	0.000121	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	1.22e-05	0.000119	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	1.21e-05	0.000118	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.19e-05	0.000116	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—APOE—multiple sclerosis	1.17e-05	0.000115	CbGpPWpGaD
Amiodarone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.17e-05	0.000114	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.000113	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.15e-05	0.000112	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—APOE—multiple sclerosis	1.12e-05	0.00011	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.1e-05	0.000107	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.1e-05	0.000107	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.09e-05	0.000106	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.08e-05	0.000105	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CD80—multiple sclerosis	1.02e-05	9.93e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—POMC—multiple sclerosis	1.01e-05	9.85e-05	CbGpPWpGaD
Amiodarone—CYP3A7—Metabolism—ALB—multiple sclerosis	1e-05	9.8e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.82e-06	9.58e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—POMC—multiple sclerosis	9.66e-06	9.43e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	9.45e-06	9.23e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.28e-06	9.06e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—APOE—multiple sclerosis	9.27e-06	9.05e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	9.25e-06	9.03e-05	CbGpPWpGaD
Amiodarone—CYP2A6—Metabolism—ALB—multiple sclerosis	9.2e-06	8.98e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—APOE—multiple sclerosis	8.75e-06	8.55e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	8.58e-06	8.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—APOE—multiple sclerosis	8.03e-06	7.83e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—POMC—multiple sclerosis	7.96e-06	7.77e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—POMC—multiple sclerosis	7.52e-06	7.34e-05	CbGpPWpGaD
Amiodarone—CYP3A5—Metabolism—ALB—multiple sclerosis	7.26e-06	7.08e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—APOE—multiple sclerosis	7.16e-06	6.99e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—BCHE—multiple sclerosis	7.16e-06	6.99e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL2—multiple sclerosis	7.14e-06	6.97e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	7.11e-06	6.94e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—APOE—multiple sclerosis	6.99e-06	6.83e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—POMC—multiple sclerosis	6.89e-06	6.73e-05	CbGpPWpGaD
Amiodarone—CYP1A1—Metabolism—ALB—multiple sclerosis	6.86e-06	6.69e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	6.76e-06	6.6e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—APOE—multiple sclerosis	6.59e-06	6.43e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—APOE—multiple sclerosis	6.53e-06	6.38e-05	CbGpPWpGaD
Amiodarone—CYP2C8—Metabolism—ALB—multiple sclerosis	6.29e-06	6.14e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—POMC—multiple sclerosis	6.15e-06	6.01e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	6.01e-06	5.87e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—POMC—multiple sclerosis	6.01e-06	5.86e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—POMC—multiple sclerosis	5.66e-06	5.53e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—POMC—multiple sclerosis	5.61e-06	5.48e-05	CbGpPWpGaD
Amiodarone—CYP2C19—Metabolism—ALB—multiple sclerosis	5.61e-06	5.48e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MYC—multiple sclerosis	5.59e-06	5.45e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—APOE—multiple sclerosis	5.58e-06	5.45e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	5.57e-06	5.44e-05	CbGpPWpGaD
Amiodarone—ABCB1—Metabolism—ALB—multiple sclerosis	5.48e-06	5.35e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	5.46e-06	5.33e-05	CbGpPWpGaD
Amiodarone—CYP2D6—Metabolism—ALB—multiple sclerosis	5.16e-06	5.04e-05	CbGpPWpGaD
Amiodarone—CYP2C9—Metabolism—ALB—multiple sclerosis	5.12e-06	4.99e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—POMC—multiple sclerosis	4.8e-06	4.68e-05	CbGpPWpGaD
Amiodarone—CYP1A2—Metabolism—ALB—multiple sclerosis	4.37e-06	4.27e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—APOE—multiple sclerosis	4.31e-06	4.21e-05	CbGpPWpGaD
Amiodarone—ADRB1—Signaling Pathways—IL6—multiple sclerosis	4.2e-06	4.1e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.7e-06	3.61e-05	CbGpPWpGaD
Amiodarone—CYP3A4—Metabolism—ALB—multiple sclerosis	3.37e-06	3.29e-05	CbGpPWpGaD
